Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 9.3% of the common stock of Haverty Furniture Companies Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in the iShares MSCI Eurozone ETF as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in the iShares MSCI France ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10% Stake in iShares MSCI Sweden ETF
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.0% beneficial ownership stake in the iShares MSCI Sweden ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in iShares 1-3 Year Treasury Bond ETF, Disclosing 6.1% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.1% beneficial ownership stake in the iShares 1-3 Year Treasury Bond ETF as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 13.6% beneficial ownership stake in ISHARES MSCI EAFE ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in iShares MSCI Kokusai ETF
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.3% in the Common Stock of ISHARES MSCI KOKUSAI ETF as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, confirming its beneficial ownership of 7.3% of the common stock in the iShares Global Industrials ETF as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Significant Passive Stake in iShares 10+ Year Investment Grade Corporate Bond ETF
BlackRock, Inc. has filed an Amendment No. 21 to its Schedule 13G, disclosing a 5.9% beneficial ownership stake in ISHARES 10+ YEAR INVESTMENT GRADE CORPORATE BOND ETF as of December 31, 2024, held for ordinary course of business.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, disclosing a continued beneficial ownership of 12.5% in Vital Energy, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 6.9% Stake in MSP Recovery, Inc. via Amended Schedule 13G Filing
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in MSP Recovery, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 12.3% of MAXIMUS INC's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, disclosing a 12.3% beneficial ownership stake in Shutterstock, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in SiteOne Landscape Supply, Inc., Disclosing 4.6% Ownership
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, reporting a passive beneficial ownership of 4.6% in SiteOne Landscape Supply, Inc. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.9% beneficial ownership stake in Texas Pacific Land Corp as of December 31, 2024, held for investment purposes in the ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 12.7% beneficial ownership stake in Titan International Inc. as of December 31, 2024, held for ordinary business purposes.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Passive 2.9% Stake in ESSA Bancorp, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.9% of ESSA Bancorp, Inc.'s common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Canadian Solar Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 7.8% Stake in Energy Fuels Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 7.8% in Energy Fuels Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 7.0% Stake in Vermilion Energy Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.0% beneficial ownership stake in Vermilion Energy Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16.3% Stake in MAC Copper Ltd
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 16.3% of MAC Copper Ltd's common stock as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 5.8% of WNS Holdings Ltd's common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Stake in Patria Investments Limited
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.7% in Patria Investments Limited as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.1% beneficial ownership stake in Wave Life Sciences Ltd. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Stake in Alerus Financial Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Alerus Financial Corp as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 9.7% of AngioDynamics Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.0% Stake in Applied Therapeutics Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Applied Therapeutics Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 18.3% Stake in Armada Hoffler Properties
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 18.3% of Armada Hoffler Properties Inc.'s common stock as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.5% Passive Stake in Capricor Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.5% beneficial ownership stake in Capricor Therapeutics Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Reduced Passive Stake in Cardiff Oncology, Inc. Below 5% Threshold
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.3% passive beneficial ownership stake in Cardiff Oncology, Inc. as of December 31, 2024.